OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
6.01
-0.06 (-0.99%)
Oct 22, 2024, 4:00 PM EDT - Market closed
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $110.11 million as of October 23, 2024. Its market cap has decreased by -7.31% in one year.
Market Cap
110.11M
Enterprise Value
131.24M
1-Year Change
-7.31%
Ranking
Category
Stock Price
$6.01
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $110.11M, an increase of 221.97%. That is a compound annual growth rate of 20.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 110.10M | -57.62% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quipt Home Medical | 126.40M |
| Outlook Therapeutics | 125.61M |
| Fennec Pharmaceuticals | 124.49M |
| 908 Devices | 124.42M |
| Veru Inc. | 123.62M |
| Eledon Pharmaceuticals | 122.91M |
| TriSalus Life Sciences | 122.82M |
| Elutia | 121.94M |